Severe complication after a doxorubicin-eluting-bead embolization: Surgical management and pathological findings

CardioVascular and Interventional Radiology

Volumn 34, Issue SUPPL. 2, 2011, Pages

  Lesevic, Veiba ^a   Marzano, Ettore ^a   Greget, Michel ^b   Rosso, Edoardo ^a   Bachellier, Philippe ^a   Pessaux, Patrick ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Chemoembolization; Complication; Doxorubicin eluting bead; Drug eluting bead; Hepatocarcinoma; Tumor necrosis

Indexed keywords

C REACTIVE PROTEIN; CILASTATIN PLUS IMIPENEM; DOXORUBICIN; METRONIDAZOLE; VANCOMYCIN;

ABDOMINAL PAIN; ABSCESS DRAINAGE; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ESCHERICHIA COLI; FEVER; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; LEUKOCYTOSIS; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER LOBECTOMY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SEPTIC SHOCK; TACHYCARDIA; TREATMENT OUTCOME; TUMOR NECROSIS;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; COMORBIDITY; DOXORUBICIN; EMERGENCIES; EPIGLOTTIS; ESCHERICHIA COLI INFECTIONS; HEPATECTOMY; HUMANS; LARYNGEAL NEOPLASMS; LIVER; LIVER ABSCESS; LIVER NEOPLASMS; MALE; MICROSPHERES; NECROSIS; NEOPLASMS, MULTIPLE PRIMARY; RECURRENCE; REOPERATION; SHOCK, SEPTIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79959748512     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-9960-5     Document Type: Article

References (11)

1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108 (Pubitemid 40372904)
2. Brown DB, Cardella JF, Sacks D et al (2006) Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 17(21):225-232
3. Malagari K, Chatzimichael K, Alexopoulou E et al (2008) Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Intervent Radiol 31(2):269-280
4. Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33(1):41-52
5. Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46(3):474-481 (Pubitemid 46201723)
6. Kothary N, Weintraub JL, Susman J et al (2007) Transarterial hemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol 18(12):1517-1526 (Pubitemid 350151875)
7. Malagari K, Alexopoulou E, Chatzimichail K et al (2008) Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdom Imaging 33(5):512-519
8. Kim W, Clark TW, Baum RA et al (2001) Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 12(8):965-968 (Pubitemid 32756867)
9. Terayama N, Matsui O, Gabata T et al (2001) Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization. Cardiovasc Intervent Radiol 24(6):383-387 (Pubitemid 34081419)
10. Castells A, Bruix J, Ayuso C et al (1995) Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. J Hepatol 22(4):410-415
11. Geschwind JF, Kaushik S, Ramsey DE et al (2002) Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 13(11):1163-1166 (Pubitemid 35332903)